• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多基因风险评分与白种人单克隆B细胞淋巴细胞增多症风险以及非裔美国人慢性淋巴细胞白血病(CLL)风险

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans.

作者信息

Kleinstern Geffen, Weinberg J Brice, Parikh Sameer A, Braggio Esteban, Achenbach Sara J, Robinson Dennis P, Norman Aaron D, Rabe Kari G, Boddicker Nicholas J, Vachon Celine M, Lesnick Connie E, Call Timothy G, Brander Danielle M, Rassenti Laura Z, Kipps Thomas J, Olson Janet E, Cerhan James R, Kay Neil E, Furman Richard R, Hanson Curtis A, Shanafelt Tait D, Slager Susan L

机构信息

School of Public Health, University of Haifa, Haifa, Israel.

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.

出版信息

Leukemia. 2022 Jan;36(1):119-125. doi: 10.1038/s41375-021-01344-9. Epub 2021 Jul 20.

DOI:10.1038/s41375-021-01344-9
PMID:34285341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8727288/
Abstract

Monoclonal B-cell lymphocytosis (MBL) is a precursor to CLL. Other than age, sex, and CLL family-history, little is known about factors associated with MBL risk. A polygenic-risk-score (PRS) of 41 CLL-susceptibility variants has been found to be associated with CLL risk among individuals of European-ancestry(EA). Here, we evaluate these variants, the PRS, and environmental factors for MBL risk. We also evaluate these variants and the CLL-PRS among African-American (AA) and EA-CLL cases and controls. Our study included 560 EA MBLs, 869 CLLs (696 EA/173 AA), and 2866 controls (2631 EA/235 AA). We used logistic regression, adjusting for age and sex, to estimate odds ratios (OR) and 95% confidence intervals within each race. We found significant associations with MBL risk among 21 of 41 variants and with the CLL-PRS (OR = 1.86, P = 1.9 × 10, c-statistic = 0.72). Little evidence of any association between MBL risk and environmental factors was observed. We observed significant associations of the CLL-PRS with EA-CLL risk (OR = 2.53, P = 4.0 × 10, c-statistic = 0.77) and AA-CLL risk (OR = 1.76, P = 5.1 × 10, c-statistic = 0.62). Inherited genetic factors and not environmental are associated with MBL risk. In particular, the CLL-PRS is a strong predictor for both risk of MBL and EA-CLL, but less so for AA-CLL supporting the need for further work in this population.

摘要

单克隆B细胞淋巴细胞增多症(MBL)是慢性淋巴细胞白血病(CLL)的前驱疾病。除年龄、性别和CLL家族史外,关于与MBL风险相关的因素知之甚少。已发现41个CLL易感性变异的多基因风险评分(PRS)与欧洲血统(EA)个体的CLL风险相关。在此,我们评估这些变异、PRS和环境因素对MBL风险的影响。我们还评估了非裔美国人(AA)和EA-CLL病例及对照中的这些变异和CLL-PRS。我们的研究纳入了560例EA MBL、869例CLL(696例EA/173例AA)和2866例对照(2631例EA/235例AA)。我们使用逻辑回归,对年龄和性别进行调整,以估计每个种族内的比值比(OR)和95%置信区间。我们发现41个变异中的21个与MBL风险以及CLL-PRS存在显著关联(OR = 1.86,P = 1.9×10,c统计量 = 0.72)。未观察到MBL风险与环境因素之间存在任何关联的明显证据。我们观察到CLL-PRS与EA-CLL风险(OR = 2.53,P = 4.0×10,c统计量 = 0.77)和AA-CLL风险(OR = 1.76,P = 5.1×10,c统计量 = 0.62)存在显著关联。与MBL风险相关的是遗传因素而非环境因素。特别是,CLL-PRS是MBL和EA-CLL风险的有力预测指标,但对AA-CLL的预测作用较小,这表明在该人群中需要进一步开展研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c052/8727288/af56ee5adac4/41375_2021_1344_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c052/8727288/af56ee5adac4/41375_2021_1344_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c052/8727288/af56ee5adac4/41375_2021_1344_Fig1_HTML.jpg

相似文献

1
Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans.多基因风险评分与白种人单克隆B细胞淋巴细胞增多症风险以及非裔美国人慢性淋巴细胞白血病(CLL)风险
Leukemia. 2022 Jan;36(1):119-125. doi: 10.1038/s41375-021-01344-9. Epub 2021 Jul 20.
2
Prevalence of monoclonal B-cell lymphocytosis: a systematic review.单克隆 B 细胞淋巴细胞增多症的患病率:系统评价。
Cytometry B Clin Cytom. 2010;78 Suppl 1(Suppl 1):S10-8. doi: 10.1002/cyto.b.20538.
3
The Clinical Usefulness of a Glaucoma Polygenic Risk Score in 4 Population-Based European Ancestry Cohorts.青光眼多基因风险评分在4个欧洲血统人群队列中的临床实用性。
Ophthalmology. 2025 Feb;132(2):228-237. doi: 10.1016/j.ophtha.2024.08.005. Epub 2024 Aug 14.
4
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.多基因风险评分与慢性淋巴细胞白血病和单克隆 B 细胞淋巴增生症风险的关联。
Blood. 2018 Jun 7;131(23):2541-2551. doi: 10.1182/blood-2017-11-814608. Epub 2018 Apr 19.
5
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
6
Alemtuzumab for patients with chronic lymphocytic leukaemia.阿仑单抗用于慢性淋巴细胞白血病患者。
Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD008078. doi: 10.1002/14651858.CD008078.pub2.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Incidence, stage and outcome of malignant melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?白癜风或斑秃患者中恶性黑色素瘤、角质形成细胞癌及其他癌症的发病率、分期和预后:个体内或家族性风险?
Br J Dermatol. 2025 Jun 20;193(1):66-73. doi: 10.1093/bjd/ljaf074.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee.单克隆B淋巴细胞增多症(MBL)的生物学前沿、进展及临床管理:血液癌症拦截研讨会委员会共识报告
Blood Cancer J. 2025 Aug 29;15(1):148. doi: 10.1038/s41408-025-01341-6.
2
Progressive T cell defects correlate with disease outcome in high-count monoclonal B-cell lymphocytosis.进展性T细胞缺陷与高计数单克隆B细胞淋巴细胞增多症的疾病预后相关。
Leukemia. 2025 Aug 20. doi: 10.1038/s41375-025-02689-1.
3
Monoclonal B-Cell Lymphocytosis: The Silent Clone the Haematologists Should Not Neglect.

本文引用的文献

1
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.多基因风险评分与慢性淋巴细胞白血病和单克隆 B 细胞淋巴增生症风险的关联。
Blood. 2018 Jun 7;131(23):2541-2551. doi: 10.1182/blood-2017-11-814608. Epub 2018 Apr 19.
2
Statistical correction of the Winner's Curse explains replication variability in quantitative trait genome-wide association studies.胜者之咒的统计校正解释了数量性状全基因组关联研究中的重复变异性。
PLoS Genet. 2017 Jul 17;13(7):e1006916. doi: 10.1371/journal.pgen.1006916. eCollection 2017 Jul.
3
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.
单克隆B细胞淋巴细胞增多症:血液科医生不应忽视的沉默克隆
Hematol Oncol. 2025 Jun;43 Suppl 2(Suppl 2):e70084. doi: 10.1002/hon.70084.
4
Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL).个体患有单克隆 B 细胞淋巴细胞增多症(MBL)时出现的镶嵌染色体改变(mCAs)。
Blood Cancer J. 2024 Nov 6;14(1):193. doi: 10.1038/s41408-024-01175-8.
5
The Epidemiological Particularities of Malignant Hemopathies in French Guiana: 2005-2014.法属圭亚那恶性血液病的流行病学特征:2005 - 2014年
Cancers (Basel). 2024 Jun 3;16(11):2128. doi: 10.3390/cancers16112128.
6
B-cell lymphocytosis in relatives of Colombian patients with chronic B-cell lymphoproliferative disorders.哥伦比亚慢性 B 细胞淋巴增殖性疾病患者亲属的 B 细胞淋巴细胞增多症。
Biomedica. 2023 Dec 29;43(Sp. 3):66-78. doi: 10.7705/biomedica.7099.
7
Relationship among three common hematological premalignant conditions.三种常见血液学癌前病变之间的关系。
Leukemia. 2023 Aug;37(8):1719-1722. doi: 10.1038/s41375-023-01914-z. Epub 2023 May 5.
8
The inherited genetic contribution and polygenic risk score for risk of CLL and MBL: a narrative review.遗传性遗传贡献和多基因风险评分与 CLL 和 MBL 风险的相关性:叙述性综述。
Leuk Lymphoma. 2023 Apr;64(4):788-798. doi: 10.1080/10428194.2022.2157215. Epub 2022 Dec 28.
9
The clonal evolution and natural history of MBL.甘露聚糖结合凝集素(MBL)的克隆进化与自然史
Blood. 2022 Oct 13;140(15):1660-1661. doi: 10.1182/blood.2022017940.
10
Role of Polygenic Risk Score in Cancer Precision Medicine of Non-European Populations: A Systematic Review.多基因风险评分在非欧洲人群癌症精准医学中的作用:系统评价。
Curr Oncol. 2022 Aug 4;29(8):5517-5530. doi: 10.3390/curroncol29080436.
全基因组关联分析提示免疫基因失调与慢性淋巴细胞白血病有关。
Nat Commun. 2017 Feb 6;8:14175. doi: 10.1038/ncomms14175.
4
Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.全基因组关联研究的荟萃分析发现了慢性淋巴细胞白血病的多个基因座。
Nat Commun. 2016 Mar 9;7:10933. doi: 10.1038/ncomms10933.
5
A global reference for human genetic variation.人类遗传变异的全球参考。
Nature. 2015 Oct 1;526(7571):68-74. doi: 10.1038/nature15393.
6
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk.12号染色体长臂24.13区(OAS3基因)的常见变异影响慢性淋巴细胞白血病风险。
Leukemia. 2015 Mar;29(3):748-51. doi: 10.1038/leu.2014.311. Epub 2014 Nov 3.
7
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.一项全基因组关联研究鉴定出慢性淋巴细胞白血病的多个易感性位点。
Nat Genet. 2014 Jan;46(1):56-60. doi: 10.1038/ng.2843. Epub 2013 Dec 1.
8
The Mayo Clinic Biobank: a building block for individualized medicine.梅奥诊所生物样本库:个体化医学的基石。
Mayo Clin Proc. 2013 Sep;88(9):952-62. doi: 10.1016/j.mayocp.2013.06.006.
9
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.全基因组关联研究鉴定出慢性淋巴细胞白血病的多个风险位点。
Nat Genet. 2013 Aug;45(8):868-76. doi: 10.1038/ng.2652. Epub 2013 Jun 16.
10
Common infectious agents and monoclonal B-cell lymphocytosis: a cross-sectional epidemiological study among healthy adults.常见感染因子与单克隆 B 细胞淋巴增生症:一项健康成年人横断面流行病学研究。
PLoS One. 2012;7(12):e52808. doi: 10.1371/journal.pone.0052808. Epub 2012 Dec 28.